Kalzin 3L Injection contains Vitamin D3 (300,000 IU) and is indicated for the treatment and prevention of vitamin D deficiency and related disorders such as rickets, osteomalacia, and hypocalcemia. This high-potency injectable formulation is designed for intramuscular administration, providing rapid and sustained correction of vitamin D levels in patients who are unable to take oral supplements or require urgent replenishment. Vitamin D3 plays a critical role in calcium and phosphate metabolism, essential for maintaining healthy bone mineralization and neuromuscular function. Kalzin 3L Injection is particularly useful in cases of severe deficiency, malabsorption syndromes, chronic renal failure, and certain metabolic bone diseases. Dosage and administration should be determined by a healthcare professional based on the severity of deficiency, patient age, and clinical condition. Monitoring of serum calcium and vitamin D levels is recommended to avoid toxicity, which may manifest as hypercalcemia, hypercalciuria, or soft tissue calcification. Contraindications include hypervitaminosis D, hypercalcemia, and hypersensitivity to any component of the formulation. Caution is advised in patients with renal impairment or granulomatous diseases. Kalzin 3L Injection should be stored according to manufacturer guidelines and used under strict medical supervision to ensure safety and efficacy.